A 34-year-old woman with severe chronic kidney disease (eGFR 18 mL/min) is taking potassium supplements for hypokalaemia secondary to renal tubular ac...

Question

A 34-year-old woman with severe chronic kidney disease (eGFR 18 mL/min) is taking potassium supplements for hypokalaemia secondary to renal tubular acidosis. She requests a POP. Which POP should be avoided?

Accepted Answer

The drospirenone POP should be avoided due to its potassium-sparing properties. Combined with potassium supplements, there is a significant risk of hyperkalaemia. Desogestrel, levonorgestrel, or norethisterone POPs are safer alternatives

Answer

All POPs are equally suitable

Answer

Only the levonorgestrel POP is safe

Answer

She cannot use any POP with CKD

Answer

Only the norethisterone POP should be avoided

uk-dfsrh MCQ (SBA): Drospirenone POP Avoid with K+ Supplements CKD

A 34-year-old woman with severe chronic kidney disease (eGFR 18 mL/min) is taking potassium supplements for hypokalaemia secondary to renal tubular acidosis. She requests a POP. Which POP should be avoided?